LONDON, November 14 /PRNewswire/ -- ASCO has chosen the Oncology Summit Europe to announce the start of their work in Europe.

Robin Bodishbaugh, Director of Licensing, Rights, & Permissions will be making a keynote presentsation telling Pharma companies how they can use a partnership with ASCO to enhance their relationships with the medical fraternity.

Held over two days from January 30-31 in London, the Summit will be a chance for pharma companies to meet ASCO and key stakeholders in the pharma Oncology Market.

As the world's leading professional organization representing physicians who treat people with cancer, ASCO is committed to advancing the education of oncologists and other oncology professionals, to advocating for policies that provide access to high-quality cancer care, and to supporting the clinical trials system and the need for increased clinical and translational research.

Members include physicians and health-care professionals participating in approved oncology training programs, oncology nurses, and other practitioners with a predominant interest in oncology.

In addition to meeting ASCO, attendees will also get the chance to hear keynote presentations from leading pharma oncology experts such as Gary Hendler, Associate VP, Oncology Marketing, Sanofi-Aventis Oncology, Uday Bose, European Marketing Director, GlaxoSmithKline Oncology , Philip Ashman, Business Unit Head, Oncology, Bayer Healthcare, Chris Teale, Director, Market Access Strategy, AstraZeneca.

For more information contact: Ed Harris Conference Director eyeforpharma eharris@eyeforpharma.com Tel: +44-207-375-7173

For more information contact: Ed Harris, Conference Director, eyeforpharma, eharris@eyeforpharma.com, Tel: +44-207-375-7173